Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics StudyJeff Wang, Hiroki Shirato, Noriko Oyama‐Manabe et al.|PLoS ONE|2015Cited by 135
Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancerHiroko Yamashita, Hirotaka Iwase|Breast Cancer Research|2005Cited by 103
Genetic heterogeneity during breast cancer progression in young patientsKanako Hagio, Hiroko Yamashita|The Breast|2021Cited by 9